一项PT-112联合吉西他滨注射液治疗晚期实体瘤患者的开放性I/II期临床研究
[Translation] An open-label phase I/II clinical study of PT-112 combined with gemcitabine injection in patients with advanced solid tumors
评估PT-112注射液联合吉西他滨注射液治疗晚期实体瘤患者的安全性和耐受性。 估PT-112注射液联合吉西他滨注射液以II期推荐剂量治疗晚期胆道癌患者的抗肿瘤作用。
[Translation] To evaluate the safety and tolerability of PT-112 injection combined with gemcitabine injection in the treatment of patients with advanced solid tumors. To evaluate the antitumor effect of PT-112 injection combined with gemcitabine injection in patients with advanced biliary tract cancer at the recommended dose in phase II.
100 Clinical Results associated with
0 Patents (Medical) associated with
100 Deals associated with
100 Translational Medicine associated with